Alexey A Soshnev
Affiliations: | Rockefeller University, New York, NY, United States |
Google:
"Alexey Soshnev"Parents
Sign in to add mentor| Pamela K. Geyer | grad student | 2006-2012 | University of Iowa Carver College of Medicine (Cell Biology Tree) |
| C. David Allis | post-doc | 2013- | Rockefeller (PombeTree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nacev BA, Dabas Y, Paul MR, et al. (2024) Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation. Nature Communications. 15: 5155 |
| Ye Z, Soshnev AA, Soto-Feliciano YM. (2023) Unlocking the Mysteries of Chromatin Biology through Functional Epigenomics. Cancer Research |
| Feng L, Barrows D, Zhong L, et al. (2023) Altered chromatin occupancy of patient-associated H4 mutants misregulate neuronal differentiation. Biorxiv : the Preprint Server For Biology |
| Zhong L, Gordillo M, Wang X, et al. (2023) Dual role of lipids for genome stability and pluripotency facilitates full potency of mouse embryonic stem cells. Protein & Cell |
| Marcelot A, Rodriguez-Tirado F, Cuniasse P, et al. (2023) A De Novo Sequence Variant in Barrier-to-Autointegration Factor Is Associated with Dominant Motor Neuronopathy. Cells. 12 |
| Soto-Feliciano YM, Sanchez-Rivera FJ, Perner F, et al. (2022) A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition. Cancer Discovery |
| Soshnev AA, Allis CD, Cesarman E, et al. (2021) Histone H1 mutations in lymphoma: a link(er) between chromatin organization, developmental reprogramming, and cancer. Cancer Research |
| Yusufova N, Kloetgen A, Teater M, et al. (2020) Histone H1 loss drives lymphoma by disrupting 3D chromatin architecture. Nature |
| Phillips RE, Soshnev AA, Allis CD. (2020) Epigenomic Reprogramming as a Driver of Malignant Glioma. Cancer Cell |
| Béguelin W, Teater M, Meydan C, et al. (2020) Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response. Cancer Cell. 37: 655-673.e11 |